Bookmark
Forward
Explore Curated Studies Results
Explore Literature Results
Explore Clinical Trials Results
QuickView for egfr protein, human (compound)
Most Correlated Studies
- L1000 CMAP - Embryonic kidney epithelial HA1E cells treated with ligand perturbagens
- L1000 CMAP - Non-small cell lung cancer HCC515 cells treated with ligand perturbagens
- L1000 CMAP - Carcinoma of prostate PC3 cells treated with ligand perturbagens
- L1000 CMAP - Prostate carcinoma VCaP cells treated with ligand perturbagens
- L1000 CMAP - Adenocarcinoma of breast MCF7 cells treated with ligand perturbagens
Most Relevant Literature
- Systematic analysis and molecular profiling of EGFR allosteric inhibitor cross-reactivity across the…
- Clinicopathologic and Molecular Subtyping of EGFR Mutation-Letter.
- Clinicopathologic and Molecular Subtyping of EGFR Mutation-Response.
- Encouraging Fussy Eaters in EGFR-Mutated Lung Cancer.
- The EGFR biomarker in tumor pathology].
Most Relevant Clinical Trials
- (SYMPHONY) Phase 1/2 Study Targeting EGFR Resistance Mechanisms in NSCLC
- (HARMONY) Study of BLU-701 in EGFR-mutant NSCLC
- Neo-DIANA: Neoadjuvant Treatment for EGFR Mutated Patients
- Osimertinib In EGFR Mutant Lung Cancer
- First in Human Study of BAY2927088 in Participants Who Have Advanced Non-small Cell Lung Cancer (NSC…
